As of April 16, 2025, Herantis Pharma Oyj (HRTIS.HE) has a market cap of $38.810 million USD. According to our data, Herantis Pharma Oyj is ranked No.8229 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $38.81 M |
-5.94%
|
Dec 29, 2024 | $41.26 M |
-3.81%
|
Dec 28, 2023 | $42.90 M |
-4.55%
|
Dec 29, 2022 | $44.94 M |
-27.71%
|
Dec 29, 2021 | $62.17 M |
-42.17%
|
Dec 29, 2020 | $0.11 B |
-46.45%
|
Dec 29, 2019 | $0.20 B |
40.91%
|
Dec 27, 2018 | $0.14 B |
2.23%
|
Dec 28, 2017 | $0.14 B |
88.77%
|
Dec 29, 2016 | $73.82 M |
159.09%
|
Dec 29, 2015 | $28.49 M |
-84.06%
|
Dec 29, 2014 | $0.18 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.52 B |
0.000 M
|
![]() Netherlands
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
Market Cap | = | HRTIS.HE Stock Price | * | HRTIS.HE Shares Outstanding |
= | $1.61 | * | 24.09 M | |
= | $38.81 M |